Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navin Khattry

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Leukemia|February 9, 2021
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, et al.
International Immunopharmacology|June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effectSaurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in IndiaShasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2022
SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational studySachin Dhumal, Amar Patil, Ashwini More, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Journal of Clinical Pathology|March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Hemasphere|April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplantPrashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Transplantation and Cellular Therapy|September 7, 2023
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited SettingsAnant Gokarn, Prashant R Tembhare, Hasan Syed, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Leukemia|February 9, 2021
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, et al.
International Immunopharmacology|June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effectSaurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in IndiaShasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2022
SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational studySachin Dhumal, Amar Patil, Ashwini More, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Journal of Clinical Pathology|March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Hemasphere|April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplantPrashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Transplantation and Cellular Therapy|September 7, 2023
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited SettingsAnant Gokarn, Prashant R Tembhare, Hasan Syed, et al.
Pageof 12